obesity + T2D, highest dose: Retatrutide: 28.3% 20.8% Semaglutide 7.2 mg: 20.7% 14.1% Orforglipron: 12.4% 10.5% Placebo-adjusted, retatrutide 12 mg delivered about two-thirds of the effect in type 2 diabetes that it delivered in the non-diabetic TRIUMPH-1 cohort 16.8 points versus 26.1 points
The Fast Facts Weight loss medications are available as a prescription for eligible people, such as individuals who have diabetes or obesity
When you do need more electrolytes, weve got you covered
Retatrutides safety and tolerability profile in human studies is defined by predominantly mild to moderate gastrointestinal effects observed during dose escalation
Additionally, 37% of Wegovy users saw improvements in fibrosis (scarring)
Function: Administered intravenously or intramuscularly, these injections aim to increase glutathione levels in the body, potentially reducing melanin production and leading to a lighter skin tone over time